{"title":"Smith+Nephew vs Stryker: Medical & surgical compared","url":"https://www.frontiertechintelligence.com/compare/smith-nephew-vs-stryker","comparison":"Stryker ranks 29 on the Robotics 100 with a score of 86; Smith+Nephew ranks 65 with 81. Stryker is ahead on positioning and leverage. Level on deployment, production, commercials, progress, technology and firepower. Smith+Nephew is based in Watford, United Kingdom, Stryker in Portage, United States. Smith+Nephew: Established. Stryker: Established. Smith+Nephew is named in 2 signals and Stryker in 10.","companies":[{"name":"Smith+Nephew","url":"https://www.frontiertechintelligence.com/companies/smith-nephew","city":"Watford","country":"United Kingdom","stage":"Established","founded":null,"last_round":null,"positioning":"Smith+Nephew's CORI handheld robotic platform (within the LSE:SN group) covers revision knee, hip, and shoulder procedures in hospital and ASC settings, with CORI XT first clinical cases in June 2026 (shoulder arthroplasty at Duke Health, knee at NYU Langone). It showcased handheld robotics at AAOS 2026. CORI-specific revenue is not broken out of the group.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":65,"score":81,"tier":"member","scores":{"gate_ne":["technology","firepower"],"leverage":6,"position":8,"progress":8,"firepower":10,"commercial":8,"deployment":8,"production":8,"technology":8},"why":"Smith+Nephew develops and sells the CORI Surgical System, a robotic-assisted platform for orthopedic surgery. Its medical robotics business qualifies as a medical and surgical robotics system.","segment":"Medical & surgical","layer":"Systems"},"signals_total":2,"facts_total":10},{"name":"Stryker","url":"https://www.frontiertechintelligence.com/companies/stryker","city":"Portage","country":"United States","stage":"Established","founded":null,"last_round":null,"positioning":"Stryker's Mako surgical-robotics franchise (within the ortho segment of Nasdaq:SYK) has 3,000+ systems installed and 2.5M procedures across 47 countries, with more than two-thirds of US Stryker knee procedures now robotic. It moved the handheld Mako RPS from limited release (February 2026) to full US launch (July 2026) with an ambulatory-surgery-center push, alongside Mako 4 multi-specialty and a shoulder application. Mako-specific figures are group-scoped and not separately disclosed.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":29,"score":86,"tier":"member","scores":{"gate_ne":["technology","firepower"],"leverage":8,"position":10,"progress":8,"firepower":10,"commercial":8,"deployment":8,"production":8,"technology":8},"why":"Stryker sells Mako SmartRobotics and handheld robotic systems that assist surgeons in joint replacement and other orthopaedic procedures.","segment":"Medical & surgical","layer":"Systems"},"signals_total":10,"facts_total":69}],"note":"Assessment by Frontier Tech Intelligence; facts and signals carry their sources."}